{"id":5670,"date":"2017-08-02T20:09:56","date_gmt":"2017-08-03T00:09:56","guid":{"rendered":"http:\/\/localhost:10028\/practiceareas\/byetta\/"},"modified":"2022-06-21T16:54:06","modified_gmt":"2022-06-21T20:54:06","slug":"byetta","status":"publish","type":"practiceareas","link":"https:\/\/www.napolilaw.com\/es\/areas-de-practica-2\/byetta\/","title":{"rendered":"Byetta Attorneys"},"content":{"rendered":"<p>La Administraci\u00f3n de Drogas y Alimentos de los EE. UU. (FDA) aprob\u00f3 Byetta (ingrediente activo exenatida) para el tratamiento de la diabetes tipo II en 2005. Administrado mediante inyecci\u00f3n, millones de personas han tomado Byetta en un esfuerzo por reducir los niveles de az\u00facar en la sangre. A pesar de su aprobaci\u00f3n federal, Byetta ha demostrado ser un f\u00e1rmaco defectuoso y peligroso. Un abogado puede ayudarlo a presentar un reclamo por da\u00f1os y perjuicios si tom\u00f3 Byetta y sufri\u00f3 da\u00f1os como resultado.<\/p>\n<p>&nbsp;<\/p>\n<h3>Byetta vinculado al c\u00e1ncer de p\u00e1ncreas y c\u00e1ncer de tiroides<\/h3>\n<p>Napoli Shkolnik, PLLC is currently investigating cases for patients who have been diagnosed pancreatic cancer and thyroid cancer\u00a0while taking or after taking Byetta. These are potentially life-threatening conditions that may have a tremendous impact on a patient and his or her family, and we are prepared to seek financial compensation that can cover medical bills, lost income and the other losses and injuries associate with these side effects. Contact our offices today, or continue reading to learn more about this type 2 diabetes medication and the side effects it may cause.<\/p>\n<p>One of the most recent developments in Byetta side effects involves pancreatic cancer. According to a new study by researchers at the University of California, Los Angeles (UCLA), evidence of pre-cancerous cellular changes were found in diabetic patients taking incretin mimetics. The Food and Drug Administration (FDA) released a Drug Safety Communication regarding this new study in March of 2013, stating that the agency would evaluate the findings of this study. Incretin mimetics are a class of diabetic drugs, including Byetta, Januvia, Victoza and several others.<\/p>\n<p>&nbsp;<\/p>\n<h3>Sobre Byetta<\/h3>\n<p>Since it was approved by the U.S. Food and Drug Administration in 2005, millions of prescriptions for Byetta (exenatide) have been dispensed across the nation. From 2005 through 2009 alone, 7 million Byetta prescriptions were dispensed. Byetta is an injectable prescription medication for the treatment of type 2 diabetes, injected twice daily within 60 minutes before the first and last meals of the day. It stimulates the production of insulin in the pancreas and causes the stomach to empty itself more slowly. Combined with diet and exercise and possibly other diabetes medications, Byetta is meant to bring blood sugar to a more optimum level.<\/p>\n<p>Byetta is not a cure for type 2 diabetes, a condition that has been diagnosed in millions of Americans. It is instead meant to control this type of diabetes by stimulating insulin production. It is estimated that many more Americans are at risk of developing type 2 diabetes or are unaware that they are in the early stages of the condition.<\/p>\n<p>With the number of patients currently suffering from type 2 diabetes, it is no wonder that so many Byetta prescriptions have been written and filled. Unfortunately, as the drug increased in popularity it became evident that patients were suffering from serious side effects.<\/p>\n<p>&nbsp;<\/p>\n<h3>Efectos secundarios peligrosos de Byetta<\/h3>\n<p>Byetta se ha relacionado con una serie de problemas de salud graves, algunos de los cuales pueden ser fatales si no se tratan. \u00c9stas incluyen:<\/p>\n<ul>\n<li>Problemas renales, incluida la insuficiencia renal; y<\/li>\n<li>Inflamaci\u00f3n del p\u00e1ncreas (pancreatitis) lo suficientemente grave como para provocar la muerte.<\/li>\n<\/ul>\n<p>De hecho, entre los a\u00f1os 2005 y 2008, la FDA recibi\u00f3 <a href=\"http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/ucm188656.htm\" target=\"_blank\" rel=\"noopener noreferrer\">78 informes de pacientes que hab\u00edan desarrollado problemas renales<\/a> como resultado directo de tomar Byetta. De estos, 18 requirieron di\u00e1lisis, dos trasplantes de ri\u00f1\u00f3n y cuatro fallecieron.<\/p>\n<p>&nbsp;<\/p>\n<h3>\u00bfTengo una causa de acci\u00f3n contra el fabricante de Byetta?<\/h3>\n<p>Si cree que ha resultado perjudicado como resultado directo de tomar Byetta, es posible que tenga una causa de acci\u00f3n contra el fabricante de Byetta, Amylin Pharmaceuticals, u otra parte a lo largo de la cadena de fabricaci\u00f3n o distribuci\u00f3n. Para recuperar los da\u00f1os en una acci\u00f3n civil, deber\u00e1 probar la negligencia del fabricante del medicamento y que el medicamento defectuoso le caus\u00f3 da\u00f1o. Los ejemplos de negligencia pueden incluir:<\/p>\n<ul>\n<li>No probar adecuadamente a Byetta antes del lanzamiento;<\/li>\n<li>No revelar datos que ilustren el riesgo de Byetta;<\/li>\n<li>No dar a conocer los riesgos (dar aviso); o y<\/li>\n<li>Fabricaci\u00f3n y distribuci\u00f3n de una droga peligrosa a pesar de los riesgos conocidos.<\/li>\n<\/ul>\n<p>Tambi\u00e9n tendr\u00e1 que probar que sus da\u00f1os no se habr\u00edan producido de no ser por tomar Byetta.<\/p>\n<p>&nbsp;<\/p>\n<h3>Emprenda acciones legales ahora para recuperar da\u00f1os<\/h3>\n<p>Although Byetta is still approved for the treatment of type 2 diabetes in adults, it is possible that patients may experience serious and life-changing side effects. Some may even be at risk of losing their lives from these. Those who have suffered injury of this kind may be entitled to financial compensation for pain, suffering, medical care and lost earnings. Future medical expenses and loss of future earnings may also be covered, depending on the case.<\/p>\n<p>Since 2000 alone, the attorneys at Napoli Shkolnik, PLLC have recovered in excess of $2 billion in settlements and awards. We are fully committed to representing the interests of the injured, helping them seek justice in the wake of the physical pain, emotional trauma and financial losses they have experienced. We go up against the most formidable opponents, negotiating fair settlements and fighting for favorable verdicts in order to help our clients begin rebuilding and moving on with their lives. We are ready to see how we can help with your Byetta lawsuit and welcome you to <a href=\"\/contact-us\/\">contacto<\/a> a <a href=\"\/practice-areas\/pharmaceutical-litigation\/\">abogado litigante farmac\u00e9utico<\/a> at our law office to discuss your rights and options. Your initial consultation is free.<\/p>\n<p>Depending upon the state in which you live, the statute of limitations for filing a defective drug claim is usually between two and four years from the date of discovery of illness. To ensure that you file a claim within the time limits, make sure you contact the attorneys at Napoli Shkolnik, PLLC as soon as possible. We are ready to meet with you today!<\/p>","protected":false},"excerpt":{"rendered":"<p>The U.S. Food &amp; Drug Administration (FDA) approved Byetta (active ingredient exenatide) for the treatment of type II diabetes in 2005. Given via injection, millions of individuals have taken Byetta&#8230;<\/p>","protected":false},"featured_media":0,"menu_order":59,"template":"","practiceareas_category":[743],"class_list":["post-5670","practiceareas","type-practiceareas","status-publish","hentry","practiceareas_category-pharmaceutical-litigation"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.napolilaw.com\/es\/wp-json\/wp\/v2\/practiceareas\/5670","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.napolilaw.com\/es\/wp-json\/wp\/v2\/practiceareas"}],"about":[{"href":"https:\/\/www.napolilaw.com\/es\/wp-json\/wp\/v2\/types\/practiceareas"}],"version-history":[{"count":0,"href":"https:\/\/www.napolilaw.com\/es\/wp-json\/wp\/v2\/practiceareas\/5670\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.napolilaw.com\/es\/wp-json\/wp\/v2\/media?parent=5670"}],"wp:term":[{"taxonomy":"practiceareas_category","embeddable":true,"href":"https:\/\/www.napolilaw.com\/es\/wp-json\/wp\/v2\/practiceareas_category?post=5670"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}